Below are current clinical trials.46 studies in Laboratory Medicine and Pathology
(open studies only).
Filter this list of studies by location, status and more.
Develop a biobank of samples from patients undergoing therapy with PCSK9 inhibitors (FDA- approved in 2015, therapeutics for hypercholesterolemia) with the goal of developing laboratory tests which may help identify best candidates for these therapies and aid in monitoring therapy efficacy.
Rochester, Minn., Scottsdale/Phoenix, Ariz.
The purpose of this study is to determine if the device being used, the Amicus apheresis device, can perform effective leukapheresis procedures and be used instead of the COBE Spectra when it is no longer available.
Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla.
The purpose of this study is to improve the interpretation of mutations in breast cancer predisposition genes. This will be accomplished by recruiting members of families found to carry deleterious (mainly protein truncating) mutations and evaluating co-segregation of the mutations with cancer within families.
The goal of this study is to validate testing to be performed in the clinical immunology lab and have a source of positive patient sera.
These tests include:
- Auto antibodies to Factor H
- C3 Nephritic Factor
- Auto antibodies to C1q
- Auto antibodies to C1INH
The purpose of this study is to collect adipose tissue from patients undergoing elective surgery, or from healthy volunteers, test the donors to assure that they comply with all regulatory aspects required of healthy donors, expand and test mesenchymal stromal cells (MSC), and bank them for future use.
The purpose of this study is to compare recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to minimize menorrhagia in women with Type 1 Von Willebrand disease.